The Role of Decavanadate in Anti-Tumour Activity

Journal Title: Global Journal of Cancer Therapy - Year 2017, Vol 3, Issue 1

Abstract

Decavanadate compounds were described to be involved in a variety of biological activities and responses such as anti-virus, anti-bacterial and anticancer. While the mechanisms of action of the anti-viral and anti-bacterial activities are better understood, the same does not go for the anti-tumour activity. Nevertheless, the inhibition of tumour proliferation seems to impact certain enzymes such as alkaline phosphatase, ecto-nucleotidases or P-type ATPases. In the present report, several studies are described, in a way to explain the increasing interest of these polyoxometalate in cancer therapy. The detailed knowledge of the molecular basis of decavanadate–proteins and cellular interactions allows to better understand the processes associated with the anticancer applications, not only for decavanadate but as well for other polyoxometalates (POMs).

Authors and Affiliations

Aureliano M

Keywords

Related Articles

The Paradoxes of Neoantigenes in Predicting Better Prognosis of Cancer Patients

Increased neoantigens of cancer generated by mutations are reported to be associated with favorable prognosis of cancer patients. The interesting findings contradict the notions that cancers were caused by accumulation o...

Financial Crisis and Health

The financial crisis has a dramatic impact on social life, since reduced or even non-existent incomes affect people’s well-being and push big parts of the population to poverty. The individuals’ financial status affects...

Abrikossoff’s Tumour Mimicking a Neoplastic Tumour of the Breast: A Case Report

Introduction: Granular cell tumours (GCT), also known as Abrikossoff’s tumours, are rare, and occur in the breast in approximately 5-6% of the cases these tumours are usually benign with only 1% of malignancy. Case Pres...

Role of tumor heterogeneity in drug resistance

Cancer is a leading cause of death in men worldwide and the major cause of cancer related death is drug resistance [1,2]. In past few years, scientists have established tumor heterogeneity as a phenomenon of critical imp...

Genetic Polymorphisms and Cisplatin- Related Nephrotoxicity

Cisplatin is one of the most widely applied antineoplastic agents used to treat different types of solid tumours. However, its use is limited by serious side- effects including nephrotoxicity. Cisplatin accumulates in pr...

Download PDF file
  • EP ID EP353628
  • DOI 10.17352/2581-5407.000015
  • Views 88
  • Downloads 0

How To Cite

Aureliano M (2017). The Role of Decavanadate in Anti-Tumour Activity. Global Journal of Cancer Therapy, 3(1), 12-14. https://europub.co.uk/articles/-A-353628